HONG KONG - China’s healthcare and biotech firms are capitalising on a surge of interest in the sector due to the coronavirus pandemic by raising a record $6.8 billion in fresh equity-linked transactions this year.
“Because of the epidemic outbreak, the biotech, healthcare industry has been valued more by everyone. People realise that no matter what the economy looks like, patients always need to see the doctor,” said Xia Yu, co-founder and CEO of Chinese biotech firm Akeso Inc 9926.HK. Loyal Valley has been looking into investment in vaccine- and testing-related companies and encouraged portfolio firms like Shanghai Junshi Biosciences to expand into businesses related to tackling the coronavirus, he said.
“It is really the scarcity value. Healthcare right now is probably the most active sector ,” said Cathy Zhang, a managing director at Morgan Stanley and head of healthcare for Global Capital Markets in Asia.HEAVILY OVERSUBSCRIBED As well as IPOs, investment banks including JPMorgan and Morgan Stanley are looking to already-listed groups to raise further funds via follow-on share sales and convertible bonds.
julie_zhuli GeniusWu They should be mass producing a vaccine to pass around the globe to make up for causing this mess
julie_zhuli GeniusWu That's more than convenient I'd say, they started this fiasco, and they've seemed to have benefited from it in more ways than one, seems more than just a coincidence 🤔🤔🤔🤔🤔
julie_zhuli GeniusWu WhoSpreadCorona ChinaSpreadCovid ChinaBehindCorona PunishChina Who Spread Corona in Russia or USA OR Africa ChinaSpread
julie_zhuli GeniusWu Win win situation for China. How convenient for them
julie_zhuli GeniusWu Вы верите в это?